{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:07:36Z","timestamp":1795036056610,"version":"4.10.2"},"reference-count":169,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In July 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the search results. Following this review, the ASH Committee on Quality agreed to continue monitoring the supporting evidence rather than revise or retire these guidelines at this time. Limited searches and expert review will be repeated annually going forward until these guidelines are revised or retired.<\/jats:p>\n                  <jats:p>Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease (SCD), but pose significant clinical challenges. Guidance for specific indications and administration of transfusion, as well as screening, prevention, and management of alloimmunization, delayed hemolytic transfusion reactions (DHTRs), and iron overload may improve outcomes.<\/jats:p>\n                  <jats:p>Objective: Our objective was to develop evidence-based guidelines to support patients, clinicians, and other healthcare professionals in their decisions about transfusion support for SCD and the management of transfusion-related complications.<\/jats:p>\n                  <jats:p>Methods: The American Society of Hematology formed a multidisciplinary panel that was balanced to minimize bias from conflicts of interest and that included a patient representative. The panel prioritized clinical questions and outcomes. The Mayo Clinic Evidence-Based Practice Research Program supported the guideline development process. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to form recommendations, which were subject to public comment.<\/jats:p>\n                  <jats:p>Results: The panel developed 10 recommendations focused on red cell antigen typing and matching, indications, and mode of administration (simple vs red cell exchange), as well as screening, prevention, and management of alloimmunization, DHTRs, and iron overload.<\/jats:p>\n                  <jats:p>Conclusions: The majority of panel recommendations were conditional due to the paucity of direct, high-certainty evidence for outcomes of interest. Research priorities were identified, including prospective studies to understand the role of serologic vs genotypic red cell matching, the mechanism of HTRs resulting from specific alloantigens to inform therapy, the role and timing of regular transfusions during pregnancy for women, and the optimal treatment of transfusional iron overload in SCD.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001143","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:40:05Z","timestamp":1580125205000},"page":"327-355","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":488,"title":["American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-6965","authenticated-orcid":false,"given":"Stella T.","family":"Chou","sequence":"first","affiliation":[{"name":"1Division of Hematology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouaz","family":"Alsawas","sequence":"additional","affiliation":[{"name":"2Mayo Clinic Evidence-Based Practice Research Program, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross M.","family":"Fasano","sequence":"additional","affiliation":[{"name":"3Center for Transfusion and Cellular Therapy, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Field","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"5Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT;"},{"name":"6Department of Pediatrics, Yale University School of Medicine, New Haven, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Howard","sequence":"additional","affiliation":[{"name":"7Department of Haematological Medicine, King's College London, London, United Kingdom;"},{"name":"8Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8565-8845","authenticated-orcid":false,"given":"Michelle","family":"Kameka","sequence":"additional","affiliation":[{"name":"9Nicole Wertheim College of Nursing and Health Sciences, Florida International University, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Kwiatkowski","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Pirenne","sequence":"additional","affiliation":[{"name":"10INSERM-U955, Laboratory of Excellence, French Blood Establishment, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-0055","authenticated-orcid":false,"given":"Patricia A.","family":"Shi","sequence":"additional","affiliation":[{"name":"11New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[{"name":"3Center for Transfusion and Cellular Therapy, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-6501","authenticated-orcid":false,"given":"Swee Lay","family":"Thein","sequence":"additional","affiliation":[{"name":"12Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Westhoff","sequence":"additional","affiliation":[{"name":"13Laboratory of Immunohematology and Genomics, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-6217","authenticated-orcid":false,"given":"Trisha E.","family":"Wong","sequence":"additional","affiliation":[{"name":"14Division of Hematology\/Oncology, Department of Pediatrics, Oregon Health and Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[{"name":"15Department of Internal Medicine, American University of Beirut, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2024052215204939100_bib1","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Sch\u00fcnemann","year":"2014","journal-title":"CMAJ"},{"key":"2024052215204939100_bib2","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Greenfield","year":"2011"},{"issue":"7","key":"2024052215204939100_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"2024052215204939100_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"2024052215204939100_bib5","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2024052215204939100_bib6","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"2024052215204939100_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2024052215204939100_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"2024052215204939100_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"2024052215204939100_bib10","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ"},{"key":"2024052215204939100_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"2024052215204939100_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"2024052215204939100_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/trf.14611","article-title":"Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline","volume":"58","author":"Compernolle","year":"2018","journal-title":"Transfusion"},{"issue":"23","key":"2024052215204939100_bib14","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/bloodadvances.2019000931","article-title":"2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations","volume":"3","author":"Murad","year":"2019","journal-title":"Blood Adv"},{"key":"2024052215204939100_bib15","volume-title":"Conflict of interest in medical research, education, and practice","author":"Lo","year":"2009"},{"issue":"11","key":"2024052215204939100_bib16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jclinepi.2014.05.006","article-title":"Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study","volume":"67","author":"Akl","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"2024052215204939100_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-152-11-201006010-00254","article-title":"The vexing problem of guidelines and conflict of interest: a potential solution","volume":"152","author":"Guyatt","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"2024052215204939100_bib18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1164\/rccm.200901-0126ST","article-title":"An official American Thoracic Society Policy statement: managing conflict of interest in professional societies","volume":"180","author":"Sch\u00fcnemann","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2024052215204939100_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2024052215204939100_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5581\/1516-8484.20130012","article-title":"Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients","volume":"35","author":"da Costa","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"6 pt 2","key":"2024052215204939100_bib21","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/trf.12987","article-title":"Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease","volume":"55","author":"Casas","year":"2015","journal-title":"Transfusion"},{"issue":"7","key":"2024052215204939100_bib22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"issue":"23","key":"2024052215204939100_bib23","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"issue":"6","key":"2024052215204939100_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"1 suppl 1","key":"2024052215204939100_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0037-1963(01)90056-3","article-title":"Current issues with blood transfusions in sickle cell disease","volume":"38","author":"Vichinsky","year":"2001","journal-title":"Semin Hematol"},{"issue":"2","key":"2024052215204939100_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"issue":"6","key":"2024052215204939100_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MOH.0000000000000277","article-title":"Red blood cell alloimmunization: new findings at the bench and new recommendations for the bedside","volume":"23","author":"Hendrickson","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"2024052215204939100_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood-2018-05-851360","article-title":"RH genotype matching for transfusion support in sickle cell disease","volume":"132","author":"Chou","year":"2018","journal-title":"Blood"},{"issue":"s1","key":"2024052215204939100_bib29","first-page":"118","article-title":"Alloimmunization in transfused sickle cell patients: effect of RBC antigen matching [abstract]","volume":"36","author":"Boateng","year":"2014","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"2024052215204939100_bib30","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/pbc.22647","article-title":"Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis","volume":"55","author":"Godfrey","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2024052215204939100_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1537-2995.1987.27187121485.x","article-title":"Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy","volume":"27","author":"Ambruso","year":"1987","journal-title":"Transfusion"},{"issue":"S1","key":"2024052215204939100_bib32","first-page":"260","article-title":"Sickle cell disease: the advantages of phenotype compatible red cells and utility of genotyping in erythrocytapheresis [abstract]","volume":"112","author":"Clucas","year":"2017","journal-title":"Vox Sang"},{"issue":"8","key":"2024052215204939100_bib33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"issue":"11","key":"2024052215204939100_bib34","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/trf.14282","article-title":"","volume":"57","author":"Yee","year":"2017","journal-title":"Transfusion"},{"issue":"7","key":"2024052215204939100_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1537-2995.1994.34794330008.x","article-title":"Antigen-matched donor blood in the transfusion management of patients with sickle cell disease","volume":"34","author":"Tahhan","year":"1994","journal-title":"Transfusion"},{"issue":"8","key":"2024052215204939100_bib36","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1537-2995.2009.02185.x","article-title":"Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion","volume":"49","author":"Ameen","year":"2009","journal-title":"Transfusion"},{"issue":"s1","key":"2024052215204939100_bib37","first-page":"628","article-title":"Successful compatible phenotype transfusion protocol to prevent alloimmunization in sickle cell disease [abstract]","volume":"100","author":"Redondo Velao","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"2024052215204939100_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1196\/annals.1345.072","article-title":"Allosensitization in patients receiving multiple blood transfusions","volume":"1054","author":"Sakhalkar","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"26","key":"2024052215204939100_bib39","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2024052215204939100_bib40","first-page":"136","article-title":"Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil","volume":"20","author":"Dias Zanette","year":"2010","journal-title":"Ethn Dis"},{"issue":"s2","key":"2024052215204939100_bib41","first-page":"S43","article-title":"Red blood cell alloimmunization in sickle cell disease in the era of extended red cell typing: a single-center experience [abstract]","volume":"62","author":"Hamideh","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2024052215204939100_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.mph.0000157789.73706.53","article-title":"Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome","volume":"27","author":"Hankins","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"21","key":"2024052215204939100_bib43","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.2144.2144","article-title":"Potential benefits of extended genotype matching to chronically transfused patients with sickle cell disease [abstract]","volume":"118","author":"Helman","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2024052215204939100_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/pbc.24530","article-title":"Alloimmunization in sickle cell anemia in the era of extended red cell typing","volume":"60","author":"O'Suoji","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"2024052215204939100_bib45","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.4761.4761","article-title":"Red cell alloimmunization in sickle cell disease: benefit of extended crossmatching in adults [abstract]","volume":"120","author":"Pulte","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2024052215204939100_bib46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"issue":"8","key":"2024052215204939100_bib47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"issue":"22","key":"2024052215204939100_bib48","article-title":"Blood transfusion in adult patients with sickle cell disease: Incidence of alloimmunization [abstract]","volume":"128","author":"Master","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2024052215204939100_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21307\/immunohematology-2019-141","article-title":"Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion","volume":"28","author":"Roberts","year":"2012","journal-title":"Immunohematology"},{"issue":"9","key":"2024052215204939100_bib50","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"issue":"5","key":"2024052215204939100_bib51","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2141.2010.08150.x","article-title":"The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults","volume":"149","author":"Kalff","year":"2010","journal-title":"Br J Haematol"},{"issue":"6","key":"2024052215204939100_bib52","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1537-2995.2002.00126.x","article-title":"Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications","volume":"42","author":"Castro","year":"2002","journal-title":"Transfusion"},{"issue":"2","key":"2024052215204939100_bib53","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/AJCP47QAAXTOZEKJ","article-title":"A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease","volume":"141","author":"Harm","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2024052215204939100_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/trf.12251","article-title":"Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions","volume":"54","author":"Unni","year":"2014","journal-title":"Transfusion"},{"issue":"3","key":"2024052215204939100_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"issue":"1","key":"2024052215204939100_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion"},{"issue":"12","key":"2024052215204939100_bib57","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/MPH.0b013e31818c9172","article-title":"Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges","volume":"30","author":"Elenga","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2024052215204939100_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/vox.12217","article-title":"The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease","volume":"108","author":"Noizat-Pirenne","year":"2015","journal-title":"Vox Sang"},{"issue":"2","key":"2024052215204939100_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4081\/hr.2013.e11","article-title":"An attempt to induce transient immunosuppression pre-erythrocytapheresis in a girl with sickle cell disease, a history of severe delayed hemolytic transfusion reactions and need for hip prosthesis","volume":"5","author":"Cattoni","year":"2013","journal-title":"Hematol Rep"},{"issue":"2","key":"2024052215204939100_bib60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tmrv.2005.11.002","article-title":"Bystander immune cytolysis","volume":"20","author":"Petz","year":"2006","journal-title":"Transfus Med Rev"},{"issue":"6","key":"2024052215204939100_bib61","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion"},{"issue":"6","key":"2024052215204939100_bib62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"2024052215204939100_bib63","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/trf.15328","article-title":"Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions","volume":"59","author":"Coleman","year":"2019","journal-title":"Transfusion"},{"issue":"5","key":"2024052215204939100_bib64","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"2024052215204939100_bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tmrv.2009.09.006","article-title":"Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review","volume":"24","author":"Win","year":"2010","journal-title":"Transfus Med Rev"},{"issue":"2","key":"2024052215204939100_bib66","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/trf.12258","article-title":"Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion","volume":"54","author":"Uhlmann","year":"2014","journal-title":"Transfusion"},{"issue":"1","key":"2024052215204939100_bib67","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/MPH.0b013e31828e529f","article-title":"Hyperhemolysis in sickle cell disease","volume":"36","author":"Aragona","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"2024052215204939100_bib68","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"issue":"6 pt 2","key":"2024052215204939100_bib69","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/trf.12993","article-title":"Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases","volume":"55","author":"Santos","year":"2015","journal-title":"Transfusion"},{"issue":"4","key":"2024052215204939100_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000441-199610000-00005","article-title":"Case reports: delayed hemolytic transfusion reaction in sickle cell disease","volume":"312","author":"Syed","year":"1996","journal-title":"Am J Med Sci"},{"issue":"2","key":"2024052215204939100_bib71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-3148.2011.01131.x","article-title":"Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report","volume":"22","author":"Win","year":"2012","journal-title":"Transfus Med"},{"issue":"10","key":"2024052215204939100_bib72","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/trf.13144","article-title":"Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab","volume":"55","author":"Boonyasampant","year":"2015","journal-title":"Transfusion"},{"issue":"3","key":"2024052215204939100_bib73","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1537-2995.2001.41030323.x","article-title":"Hyperhemolytic transfusion reaction in sickle cell disease","volume":"41","author":"Win","year":"2001","journal-title":"Transfusion"},{"issue":"1","key":"2024052215204939100_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jhm.257","article-title":"Hyperhemolysis syndrome: a relative contraindication for transfusion","volume":"3","author":"Lu","year":"2008","journal-title":"J Hosp Med"},{"issue":"5-6","key":"2024052215204939100_bib75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10245330400001926","article-title":"Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease","volume":"9","author":"Win","year":"2004","journal-title":"Hematology"},{"key":"2024052215204939100_bib76","doi-asserted-by":"crossref","first-page":"812934","DOI":"10.1155\/2015\/812934","article-title":"Alloimmunization in patients with sickle cell disease in French Guiana","volume":"2015","author":"Elenga","year":"2015","journal-title":"J Blood Transfus"},{"issue":"12","key":"2024052215204939100_bib77","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.12074","article-title":"Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease","volume":"92","author":"Noizat-Pirenne","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"2024052215204939100_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5694\/j.1326-5377.2010.tb03509.x","article-title":"Hyperhaemolysis in sickle cell disease--an unusual and potentially life-threatening complication","volume":"192","author":"Stokes","year":"2010","journal-title":"Med J Aust"},{"issue":"6","key":"2024052215204939100_bib79","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3324\/haematol.2010.038307","article-title":"Delayed hemolytic transfusion reaction in children with sickle cell disease","volume":"96","author":"de Montalembert","year":"2011","journal-title":"Haematologica"},{"issue":"10","key":"2024052215204939100_bib80","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"issue":"4","key":"2024052215204939100_bib81","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tmrv.2015.06.001","article-title":"Hyperhemolysis in patients with hemoglobinopathies: a single-center experience and review of the literature","volume":"29","author":"Danaee","year":"2015","journal-title":"Transfus Med Rev"},{"issue":"2","key":"2024052215204939100_bib82","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/MPH.0000000000000241","article-title":"Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease","volume":"37","author":"Ipe","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"25","key":"2024052215204939100_bib83","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2024052215204939100_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"2024052215204939100_bib85","article-title":"Comparison of transfusion adverse events in sickle cell disease patients receiving simple transfusions or automated red cell exchange for stroke prevention","author":"Kelly","year":"6-9  2015","journal-title":"Proceedings from the American Society of Apheresis Annual Meeting"},{"issue":"1","key":"2024052215204939100_bib86","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00043426-199602000-00009","article-title":"Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients","volume":"18","author":"Adams","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"2024052215204939100_bib87","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/trf.13558","article-title":"Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients","volume":"56","author":"Fasano","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"2024052215204939100_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<28::AID-AJH6>3.0.CO;2-1","article-title":"Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients","volume":"59","author":"Hilliard","year":"1998","journal-title":"Am J Hematol"},{"issue":"4","key":"2024052215204939100_bib89","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V83.4.1136.1136","article-title":"Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease","volume":"83","author":"Kim","year":"1994","journal-title":"Blood"},{"issue":"2","key":"2024052215204939100_bib90","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/trf.12875","article-title":"Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease","volume":"55","author":"Michot","year":"2015","journal-title":"Transfusion"},{"issue":"8","key":"2024052215204939100_bib91","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/pbc.26017","article-title":"Transfusional iron overload in a cohort of children with sickle cell disease: impact of magnetic resonance imaging, transfusion method, and chelation","volume":"63","author":"Stanley","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2024052215204939100_bib92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pbc.22985","article-title":"Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease","volume":"57","author":"Venkateswaran","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2024052215204939100_bib93","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1537-2995.2012.03659.x","article-title":"Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions","volume":"52","author":"Wahl","year":"2012","journal-title":"Transfusion"},{"issue":"3","key":"2024052215204939100_bib94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.transci.2005.03.003","article-title":"Chronic red blood cell exchange to prevent clinical complications in sickle cell disease","volume":"32","author":"Cabibbo","year":"2005","journal-title":"Transfus Apheresis Sci"},{"issue":"6","key":"2024052215204939100_bib95","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/trf.14575","article-title":"Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload","volume":"58","author":"Dedeken","year":"2018","journal-title":"Transfusion"},{"issue":"2","key":"2024052215204939100_bib96","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.transci.2012.09.002","article-title":"Long-term red blood cell exchange in children with sickle cell disease: manual or automatic?","volume":"48","author":"Duclos","year":"2013","journal-title":"Transfus Apheresis Sci"},{"issue":"5","key":"2024052215204939100_bib97","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/trf.13548","article-title":"Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia","volume":"56","author":"Koehl","year":"2016","journal-title":"Transfusion"},{"issue":"3","key":"2024052215204939100_bib98","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.13294","article-title":"A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients","volume":"170","author":"Kuo","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"2024052215204939100_bib99","first-page":"CD007843","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","author":"Alhashimi","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2024052215204939100_bib100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.20344\/amp.8228","article-title":"Partial red blood cell exchange in children and young patients with sickle cell disease: manual versus automated procedure","volume":"30","author":"Escobar","year":"2017","journal-title":"Acta Med Port"},{"issue":"23","key":"2024052215204939100_bib101","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"2024052215204939100_bib102","volume-title":"A sickle crisis? A report of the National Confidential Enquiry into Patient Outcome and Death","author":"Lucas","year":"2008&gt;"},{"issue":"6","key":"2024052215204939100_bib103","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3476(95)70025-0","article-title":"Effect of transfusion in acute chest syndrome of sickle cell disease","volume":"127","author":"Emre","year":"1995","journal-title":"J Pediatr"},{"issue":"12","key":"2024052215204939100_bib104","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/pbc.24744","article-title":"Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome","volume":"60","author":"Saylors","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024052215204939100_bib105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1537-2995.2008.02075.x","article-title":"Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults","volume":"49","author":"Turner","year":"2009","journal-title":"Transfusion"},{"issue":"25","key":"2024052215204939100_bib106","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"10","key":"2024052215204939100_bib107","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1182\/blood-2014-09-599852","article-title":"Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia [published correction appears in Blood. 2015;125(10):1516-1517]","volume":"125","author":"Bernaudin","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2024052215204939100_bib108","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood-2012-01-406314","article-title":"Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease","volume":"120","author":"Dowling","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2024052215204939100_bib109","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran","year":"1992","journal-title":"J Pediatr"},{"issue":"3","key":"2024052215204939100_bib110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/mpd.2001.117070","article-title":"Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease","volume":"139","author":"Wierenga","year":"2001","journal-title":"J Pediatr"},{"issue":"4","key":"2024052215204939100_bib111","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jca.20294","article-title":"Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients","volume":"26","author":"Sarode","year":"2011","journal-title":"J Clin Apher"},{"issue":"4","key":"2024052215204939100_bib112","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/trf.12891","article-title":"The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease","volume":"55","author":"Quirolo","year":"2015","journal-title":"Transfusion"},{"issue":"2","key":"2024052215204939100_bib113","first-page":"100","article-title":"Developing and growing a chronic red cell exchange program: a single institution experience [abstract]","volume":"31","author":"Castro","year":"2016","journal-title":"J Clin Apher"},{"issue":"2","key":"2024052215204939100_bib114","first-page":"96","article-title":"Surveillance of post-procedure red cell gain\/loss following red cell exchange procedures with and without depletion in pediatric sickle cell patients: a single institution experience [abstract]","volume":"31","author":"Su","year":"2016","journal-title":"J Clin Apher"},{"issue":"2","key":"2024052215204939100_bib115","first-page":"97","article-title":"Effect of isovolemic hemodilution-red blood exchange on iron balance in sickle cell patients [abstract]","volume":"31","author":"Usmani","year":"2016","journal-title":"J Clin Apher"},{"issue":"6","key":"2024052215204939100_bib116","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.AOG.0000127433.23611.54","article-title":"Outcome of pregnancy in homozygous sickle cell disease","volume":"103","author":"Serjeant","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"21","key":"2024052215204939100_bib117","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2024052215204939100_bib118","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hoc.2005.07.003","article-title":"Pregnancy and sickle cell disease","volume":"19","author":"Hassell","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"2024052215204939100_bib119","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semperi.2013.04.006","article-title":"Sickle cell crisis and pregnancy","volume":"37","author":"Parrish","year":"2013","journal-title":"Semin Perinatol"},{"issue":"2","key":"2024052215204939100_bib120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ogc.2010.02.015","article-title":"Sickle cell disease in pregnancy","volume":"37","author":"Rogers","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"3","key":"2024052215204939100_bib121","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1542\/peds.2006-2768","article-title":"The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease","volume":"120","author":"Thame","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"2024052215204939100_bib122","first-page":"698","article-title":"Study of placenta in sickle cell disorders","volume":"50","author":"Rathod","year":"2007","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"2024052215204939100_bib123","first-page":"516","article-title":"The use of prophylactic partial exchange tranfusion in pregnancies associated with sickle cell hemoglobinopathies","volume":"48","author":"Morrison","year":"1976","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2024052215204939100_bib124","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9378(16)32625-4","article-title":"Management of sickle hemoglobinopathies in pregnant patients","volume":"141","author":"Miller","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2024052215204939100_bib125","first-page":"419","article-title":"Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusions","volume":"62","author":"Cunningham","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2024052215204939100_bib126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1471-0528.1987.tb02337.x","article-title":"Prophylactic blood transfusion in maternal sickle cell syndromes","volume":"94","author":"Tuck","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"2024052215204939100_bib127","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jca.2920060411","article-title":"Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease","volume":"6","author":"Morrison","year":"1991","journal-title":"J Clin Apher"},{"issue":"4","key":"2024052215204939100_bib128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1479-828X.1995.tb02153.x","article-title":"Indications for blood transfusion in pregnancy with sickle cell disease","volume":"35","author":"El-Shafei","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"12","key":"2024052215204939100_bib129","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1471-0528.1995.tb10900.x","article-title":"Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome","volume":"102","author":"Howard","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"2024052215204939100_bib130","first-page":"603","article-title":"Severe sickle cell disease and pregnancy. Systematic prophylactic transfusions in 16 cases [in French]","volume":"62","author":"Moussaoui","year":"2002","journal-title":"Med Trop (Mars)"},{"issue":"1","key":"2024052215204939100_bib131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijgo.2006.09.017","article-title":"Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease","volume":"96","author":"Gilli","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"2024052215204939100_bib132","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/trf.12780","article-title":"Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy","volume":"55","author":"Asma","year":"2015","journal-title":"Transfusion"},{"issue":"1","key":"2024052215204939100_bib133","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/trf.13280","article-title":"The effects of exchange transfusion for prevention of complications during pregnancy of sickle hemoglobin C disease patients","volume":"56","author":"Benites","year":"2016","journal-title":"Transfusion"},{"issue":"4","key":"2024052215204939100_bib134","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jca.2920060412","article-title":"Management of sickle cell anemia and pregnancy","volume":"6","author":"Koshy","year":"1991","journal-title":"J Clin Apher"},{"issue":"22","key":"2024052215204939100_bib135","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study","volume":"319","author":"Koshy","year":"1988","journal-title":"N Engl J Med"},{"issue":"21","key":"2024052215204939100_bib136","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2015-06-649319","article-title":"Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis","volume":"126","author":"Malinowski","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2024052215204939100_bib137","first-page":"164","article-title":"Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anaemia","volume":"28","author":"Al-Jaouni","year":"2006","journal-title":"Bahrain Med Bull"},{"issue":"9870","key":"2024052215204939100_bib138","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"2024052215204939100_bib139","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"2024052215204939100_bib140","first-page":"983","article-title":"Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery","volume":"19","author":"Al-Samak","year":"2008","journal-title":"Middle East J Anaesthesiol"},{"issue":"4","key":"2024052215204939100_bib141","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4293\/108680811X13176785203996","article-title":"Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy","volume":"15","author":"Aziz","year":"2011","journal-title":"JSLS"},{"issue":"4","key":"2024052215204939100_bib142","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00000658-198804000-00011","article-title":"Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies","volume":"207","author":"Bischoff","year":"1988","journal-title":"Ann Surg"},{"issue":"1","key":"2024052215204939100_bib143","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0609.2005.00412.x","article-title":"Preoperative transfusion in sickle cell disease: a survey of practice in England","volume":"75","author":"Buck","year":"2005","journal-title":"Eur J Haematol"},{"issue":"21","key":"2024052215204939100_bib144","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.4189.4189","article-title":"Preoperative transfusion practices and outcomes in sickle cell patients admitted to California hospitals [abstract]","volume":"118","author":"Claster","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2024052215204939100_bib145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5301\/hipint.5000317","article-title":"Cementless total hip replacements in sickle cell disease","volume":"26","author":"Jack","year":"2016","journal-title":"Hip Int"},{"issue":"1","key":"2024052215204939100_bib146","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tracli.2012.11.001","article-title":"Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique","volume":"20","author":"Ould Amar","year":"2013","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"2024052215204939100_bib147","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-3468(05)80359-8","article-title":"Perioperative management for cholecystectomy in sickle cell disease","volume":"28","author":"Bhattacharyya","year":"1993","journal-title":"J Pediatr Surg"},{"issue":"3","key":"2024052215204939100_bib148","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-3468(81)80683-5","article-title":"Preoperative exchange transfusion in sickle cell anemia","volume":"16","author":"Fullerton","year":"1981","journal-title":"J Pediatr Surg"},{"issue":"2","key":"2024052215204939100_bib149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0022-3468(80)80001-7","article-title":"Perioperative management of children with sickle hemoglobinopathy","volume":"15","author":"Janik","year":"1980","journal-title":"J Pediatr Surg"},{"issue":"1","key":"2024052215204939100_bib150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000658-198807000-00003","article-title":"Elective cholecystectomy in children with sickle hemoglobinopathies. Successful outcome using a preoperative transfusion regimen","volume":"208","author":"Ware","year":"1988","journal-title":"Ann Surg"},{"issue":"4","key":"2024052215204939100_bib151","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2006.06332.x","article-title":"Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease","volume":"135","author":"Fung","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"2024052215204939100_bib152","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.2830420116","article-title":"Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major","volume":"42","author":"Brittenham","year":"1993","journal-title":"Am J Hematol"},{"issue":"5","key":"2024052215204939100_bib153","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N Engl J Med"},{"key":"2024052215204939100_bib154","first-page":"628150","article-title":"Hepatic iron quantification on 3 tesla (3 T) magnetic resonance (MR): technical challenges and solutions","volume":"2013","author":"Anwar","year":"2013","journal-title":"Radiol Res Pract"},{"issue":"2","key":"2024052215204939100_bib155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance","volume":"105","author":"St Pierre","year":"2005","journal-title":"Blood"},{"issue":"4","key":"2024052215204939100_bib156","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"issue":"20","key":"2024052215204939100_bib157","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"2024052215204939100_bib158","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/08880018.2011.630774","article-title":"Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload","volume":"29","author":"Kaushik","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"2024052215204939100_bib159","doi-asserted-by":"crossref","first-page":"e0172147","DOI":"10.1371\/journal.pone.0172147","article-title":"Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome","volume":"12","author":"de Montalembert","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"2024052215204939100_bib160","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ajh.23721","article-title":"Cardiac iron overload in sickle-cell disease","volume":"89","author":"Meloni","year":"2014","journal-title":"Am J Hematol"},{"issue":"21","key":"2024052215204939100_bib161","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2009-02-203323","article-title":"Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury","volume":"114","author":"Adamkiewicz","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2024052215204939100_bib162","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MPH.0b013e3181a1c143","article-title":"Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy","volume":"31","author":"Brown","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2024052215204939100_bib163","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajh.22228","article-title":"Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention","volume":"87","author":"Kwiatkowski","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"2024052215204939100_bib164","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajh.23650","article-title":"Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload","volume":"89","author":"Puliyel","year":"2014","journal-title":"Am J Hematol"},{"issue":"2","key":"2024052215204939100_bib165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ejh.12230","article-title":"Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease","volume":"92","author":"Tsitsikas","year":"2014","journal-title":"Eur J Haematol"},{"issue":"3","key":"2024052215204939100_bib166","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MPG.0000000000000235","article-title":"Ferritin and LIC: predicting liver injury in children with sickle cell","volume":"58","author":"Smith","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"2024052215204939100_bib167","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24089","article-title":"Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial","volume":"90","author":"Wood","year":"2015","journal-title":"Am J Hematol"},{"key":"2024052215204939100_bib168","unstructured":"Sickle Cell Society\n              \n            \n          . Standard for Clinical Care of Adults with Sickle Cell Disease in the UK. Accessed 31 August 2019. https:\/\/www.sicklecellsociety.org\/wp-content\/uploads\/2018\/05\/Standards-for-the-Clinical-Care-of-Adults-with-Sickle-Cell-in-the-UK-2018.pdf."},{"issue":"2","key":"2024052215204939100_bib169","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.gaceta.2017.03.008","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines [in Spanish]","volume":"32","author":"Alonso-Coello","year":"2018","journal-title":"Gac Sanit"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/2\/327\/2223641\/blooda-31664-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/2\/327\/2223641\/blooda-31664-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:22:10Z","timestamp":1716376930000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/2\/327\/440607\/American-Society-of-Hematology-2020-guidelines-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001143","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737277028.793577975","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]}}}